Exane Derivatives’s Nutrien NTR Stock Holding History

Exane Derivatives’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$10.3K	Sell	130 -6,701	-98%	-$651K	0.01%	388
2022 Q1	$706K	Sell	6,831 -1,590	-19%	-$132K	0.2%	133
2021 Q4	$631K	Buy	8,421 +519	+7%	+$36.3K	0.15%	148
2021 Q3	$510K	Buy	+7,902	New	+$483K	0.12%	188

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Exane Derivatives's NTR Position: Q2 2022 in Review

Exane Derivatives reduced its Nutrien (NTR) stake by 98% in Q2 2022, selling an estimated $651K and leaving 130 shares worth $10.3K. The position accounts for 0.01% of the portfolio, ranked #388.

Exane Derivatives first reported a position in NTR in Q3 2021 and has held it in 4 quarters since. The position peaked at $706K in Q1 2022. 742 funds tracked by Wall St. Rank hold NTR as of Q2 2022.

Exane Derivatives held 130 shares of Nutrien worth $10.3K as of Q2 2022.
Exane Derivatives sold 6,701 Nutrien shares in Q2 2022, an estimated $651K.
Nutrien made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #388 holding.
Exane Derivatives first reported a position in Nutrien in Q3 2021 and has held it in 4 quarters since.
Exane Derivatives's Nutrien position peaked at $706K in Q1 2022.
742 funds tracked by Wall St. Rank held Nutrien as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.